High materiality7/10
Eloxx Pharmaceuticals initiated with an Outperform at Leerink Partners
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst Leerink Partners initiates Eloxx with Outperform; target 32 vs 17.55.
- Leerink Partners initiates Eloxx with Outperform; target 32 vs 17.55.
Key facts
- 01
Target: $32
- 02
Posted price: $17.55
- 03
Analyst firm: Leerink Partners
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.